Line 54: | Line 54: | ||
<a href="https://2016.igem.org/Team:MIT/Human_Practices"> | <a href="https://2016.igem.org/Team:MIT/Human_Practices"> | ||
<img src="https://static.igem.org/mediawiki/2016/d/d7/T--MIT--Homepage2humans.svg" alt="human practices" width="950px" > | <img src="https://static.igem.org/mediawiki/2016/d/d7/T--MIT--Homepage2humans.svg" alt="human practices" width="950px" > | ||
− | <span class="text-content"><span | + | <span class="text-content"><span><br><br><br><br><br><br><br><br><br><br><br><br>Read more about our integrated human practices, mammalian synthetic biology toolbox, and public outreach<br><br></span></span> |
</a> | </a> | ||
</li> | </li> |
Revision as of 14:48, 17 October 2016
-
Read more about endometriosis
-
We created new, synthetic promoters to respond to this disease marker
-
We characterized miRNA profiles in model cells under varying conditions
-
We characterized a serine integrase, TP901, that could give a genetic circuit memory across a cycle
-
Read about a summary of our results and how our sensors interact logically after transfection of
4 to 5-unit genetic circuits into model cell cultures
-
Read about how we worked with other iGEM teams throughout our project
-
Read more about the future of our work through circuit design and clinical application
-
Read more about our integrated human practices, mammalian synthetic biology toolbox, and public outreach